Aster DM Healthcare rises on getting nod to acquire additional 13% stake in DRCM
Aster DM Healthcare is currently trading at Rs. 594.20, up by 3.25 points or 0.55% from its previous closing of Rs. 590.95 on the BSE.
The scrip opened at Rs. 594.85 and has touched a high and low of Rs. 598.80 and Rs. 588.50 respectively. So far 18930 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 674.15 on 03-Jul-2025 and a 52 week low of Rs. 335.50 on 30-Jul-2024.
Last one week high and low of the scrip stood at Rs. 603.65 and Rs. 572.85 respectively. The current market cap of the company is Rs. 30812.66 crore.
The promoters holding in the company stood at 40.39%, while Institutions and Non-Institutions held 44.92% and 14.69% respectively.
Aster DM Healthcare has received approval for acquisition of additional 13% shares in Dr. Ramesh Cardiac & Multispecialty Hospital, subsidiary (DRCM). The company had entered into a Shareholders Agreement (SHA) with DRCM and its Promoter and Promoter Group on April 30, 2016. In accordance with the terms of Put Option in SHA, the promoter group of DRCM has exercised their right to sell a collective 13% stake by issuing a Put notice dated March 5, 2025.
With this acquisition, the shareholding of the company in DRCM increases from 57.49% to 70.49%. Cost of Acquisition is Rs 63.01 crore. The said acquisition is expected to be completed within the next 1–2 months. The Investment and Finance committee at its meeting held on July 30, 2025, inter alia, approved the same.
Aster DM Healthcare operates in multiple segments of the healthcare industry, including hospitals, clinics and retail pharmacies and provide healthcare services to patients across economic segments in several GCC states through its various brands ‘Aster’, ‘Medcare’ and ‘Access’.
